Sales & Marketing Disrupted medical conferences: Lessons learnt The new normal is already here. Get used to it.
Views & Analysis Are face-to-face medical meetings a thing of the past? Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception.
Views & Analysis What pharma can do to win in virtual Early data indications from the first virtual congresses shows big changes are needed.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
